AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Skye Bioscience, Inc. Director's Dealing 2014

Nov 11, 2014

34097_dirs_2014-11-10_3c0cef40-9c09-4997-9a72-e47871fa37d0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Nemus Bioscience, Inc. (LGLRD)
CIK: 0001516551
Period of Report: 2014-10-31

Reporting Person: MENDEZ FRANCISCO JAVIER (former Officer, Director, 10%)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-10-31	Common Stock	J	1180000	—	Disposed	0	Direct

Footnotes

F1: Shares were cancelled pursuant to the Stock Repurchase and Cancellation Agreement filed as Exhibit 10.2 to the Issuer's Current Report on Form 8-K filed on November 3, 2014.

F2: Post Split